Coloboma of the Choroid and Retina

Coloboma of the choroid and retina (often called chorioretinal coloboma) is a birth defect of the back part of the eye. In this condition, there is a missing piece or “gap” in the retina (the light-sensitive layer) and the choroid (the blood-rich layer under the retina). This gap is present from birth and usually sits in the lower inner part of the eye. Because the retina and choroid are not fully formed in that area, vision can be weak or missing in the affected part of the visual field. This problem happens when a normal gap in the developing eye, called the optic or choroidal fissure, does not close properly in early pregnancy. Normally this fissure closes by around the fifth to sixth week of gestation. If closure is incomplete, the eye tissue in that area does not form, and a coloboma is left behind.

Coloboma of the choroid and retina is a birth defect where a part of the back of the eye (the retina, retinal pigment epithelium, and choroid) does not form completely, leaving a gap or crater-like area, usually in the lower inside part of the fundus. This happens when a small groove in the developing eye (the embryonic fissure) fails to close in early pregnancy. Vision may be normal if the central retina is spared, or severely reduced if the macula or optic disc is involved. Coloboma itself cannot be “cured”, but many of its complications can be treated and vision can often be improved or protected.

Coloboma of the choroid and retina carries a higher risk of serious problems over time, especially retinal detachment, choroidal neovascularization (new, leaky blood vessels under the retina), cataract, and sometimes glaucoma. These complications may cause sudden floaters, flashes, a curtain over vision, or a steady drop in central vision. Lifelong follow-up with a retina specialist is therefore very important for early detection and treatment of these problems.

Choroid and retina coloboma can affect one eye or both eyes. Some people have only a small defect and almost normal vision. Others have large defects, small eyes (microphthalmia), and serious vision loss. Many patients are also at higher risk of problems such as retinal detachment (the retina peeling off) and abnormal new blood vessels under the retina (choroidal neovascularization). These complications can suddenly reduce vision and may need urgent treatment.

Chorioretinal coloboma may occur alone or together with other eye problems such as cataract, glaucoma, nystagmus (eye shaking), and squint (strabismus). In some people it is part of a wider syndrome that also affects the brain, ears, kidneys, heart, or body growth. In others, no other problem is found and the coloboma seems isolated.

Other names

Coloboma of the choroid and retina is also known by several other names. One common term is chorioretinal coloboma, which simply joins the names of the two affected layers (choroid and retina).

Doctors may also use the terms posterior segment coloboma, retinochoroidal coloboma, or uveal coloboma involving choroid and retina. “Posterior segment” means the back part of the eye. “Uveal” refers to the pigmented vascular layer of the eye, which includes the choroid. All of these names point to the same basic idea: a congenital gap in the deeper layers at the back of the eye.

Types of coloboma of choroid and retina

There are several ways to describe types of choroid and retina coloboma. The exact type depends on size, position, and what other structures are involved.

1. Typical inferonasal chorioretinal coloboma
   This is the “classic” type. The defect lies in the lower inner part of the fundus, following the path of the embryonic fissure. It often looks like a white or pale bowl-shaped area with thin or absent retina and choroid. This is the most common form described in textbooks.

2. Atypical chorioretinal coloboma
   In some people, the gap is in a non-typical area, such as more temporal or superior (upper) parts of the retina. These are called atypical colobomas because they do not follow the usual fissure line but still show missing tissue and similar visual problems.

3. Macular coloboma-like defect
   Sometimes the central retina (macula) has a punched-out, scar-like defect that behaves like a coloboma. It may be a true coloboma or a coloboma-like lesion from other causes, but clinically it is often grouped with macular coloboma. Vision is often more affected because the macula is responsible for sharp central sight.

4. Choroidal coloboma with optic disc involvement
   In many eyes the coloboma includes not only the choroid and retina but also the optic nerve head. This optic disc coloboma can further reduce vision and is often linked with field defects and a higher risk of retinal detachment around the coloboma border.

5. Isolated chorioretinal coloboma
   In this type, the only eye problem is the coloboma itself. The person has no major systemic (body-wide) syndrome, although there may still be small differences such as mild microphthalmia. Many case reports describe patients with only one abnormal eye of this kind.

6. Syndromic chorioretinal coloboma
   Here, the coloboma is part of a broader syndrome such as CHARGE syndrome, PAX2-related (renal coloboma) syndrome, or other genetic syndromes. These patients often have multiple organ problems and may need care from several specialists.

7. Unilateral coloboma
   Only one eye has the chorioretinal coloboma. The other eye looks normal or has much milder changes. People with unilateral disease often have better overall vision because the healthy eye can compensate.

8. Bilateral coloboma
   Both eyes have choroid and retina defects. This is more likely to cause serious low vision or legal blindness, especially if both maculae are involved or if there are repeated retinal detachments. Bilateral disease is seen more often in some genetic and chromosomal syndromes.

9. Coloboma with microphthalmia
   In some babies the eye is small (microphthalmic) as well as colobomatous. The small globe and large posterior defect can both worsen vision and increase the risk of retinal detachment and other complications.

10. Coloboma with retinal detachment
    Some patients are described as having chorioretinal coloboma with active or past retinal detachment. In these cases, the focus is on both the structural defect and the complications, and they may need repeated vitreoretinal surgeries.

Causes of coloboma of choroid and retina

Researchers know that coloboma of the choroid and retina is mainly a developmental problem from failure of closure of the embryonic fissure, but the reasons behind this failure are many and often mixed.

1. Simple developmental error in eye formation
   In many patients, no clear trigger is found. The fissure in the early eye simply does not close completely for unknown reasons. This “sporadic” developmental accident is thought to be a common cause, especially when there is no family history or syndrome.

2. New (de novo) gene changes in eye-development genes
   Sometimes a child has a new mutation in a gene that guides eye development. The parents do not carry this change. These random new variants can disrupt the normal closure of the fissure and lead to coloboma of the choroid and retina.

3. PAX2-related (renal coloboma) syndrome
   Changes in the PAX2 gene can cause a syndrome with kidney malformations and optic nerve or retinochoroidal colobomas. This autosomal dominant condition shows that single-gene defects can directly produce posterior segment coloboma.

4. CHARGE syndrome (CHD7 mutation)
   CHARGE syndrome includes coloboma, heart defects, choanal atresia, growth delay, genital anomalies, and ear abnormalities. Most cases are due to mutations in the CHD7 gene, which affects many steps in eye and body development, including fissure closure.

5. Other coloboma-linked genetic syndromes
   Coloboma of the choroid and retina can appear in several other syndromes like Aicardi syndrome, branchio-oculo-facial syndrome, and focal dermal hypoplasia. These conditions reflect broader genetic errors that disturb eye and brain development at similar stages.

6. Chromosomal abnormalities (e.g., trisomy 13 or 18)
   Extra or missing chromosome pieces can disturb many organs, including the eyes. Coloboma is reported in some babies with trisomy 13, trisomy 18, and other chromosomal syndromes, showing that large-scale genomic changes can be an upstream cause.

7. Disorders of vitamin A (retinoic acid) signaling
   Vitamin A and its active form retinoic acid are vital for eye patterning. Animal and human studies show that both deficiency and disturbed RA signaling can lead to coloboma and microphthalmia, because the signaling gradient that guides fissure closure is altered.

8. Maternal vitamin A deficiency
   When a pregnant woman has very low vitamin A stores, the fetus may not receive enough retinoids for normal eye formation. Recent work suggests that severe deficiency can contribute to congenital eye malformations, including coloboma, especially in settings with poor nutrition.

9. Maternal vitamin A / retinoid excess or teratogenic doses
   Very high doses of vitamin A or retinoid drugs (such as some acne medicines) in early pregnancy are teratogenic. They can disrupt eye morphogenesis and have been associated with severe birth defects. Coloboma is one of the defects reported in the context of disturbed retinoid exposure.

10. Fetal alcohol spectrum disorder (maternal alcohol use)
    Alcohol is a known teratogen. Children with fetal alcohol spectrum disorders often have eye problems, including microphthalmia and coloboma. Animal models also show that alcohol during crucial days of gestation can lead to coloboma-like defects.

11. Other prenatal drug exposures that affect eye morphogenesis
    Reviews of prenatal medication exposure show that several drugs can disturb eye development. These medicines may alter cell survival or migration in the developing eye, increasing the risk of structural defects such as uveal coloboma.

12. Maternal diabetes and other systemic illnesses in pregnancy
    Maternal diabetes and some other systemic conditions can raise the risk of craniofacial and ocular malformations. These conditions may interact with genetic factors and vitamin A pathways, contributing to incomplete fissure closure and coloboma in some fetuses.

13. Maternal hypothyroidism and other hormonal disturbances
    Some studies exploring possible environmental causes of uveal coloboma have suggested higher rates of maternal hypothyroidism in affected pregnancy cohorts, although evidence is still limited. Hormonal imbalances may interact with other developmental pathways in the embryo.

14. Intrauterine infections (e.g., congenital rubella and others)
    Certain perinatal infections can damage the developing eye, leading to cataracts, pigmentary retinopathy, and sometimes structural defects like coloboma. Viral damage during the narrow window when the fissure should close can interfere with normal tissue formation.

15. Family history with autosomal dominant inheritance
    In some families, coloboma of choroid and retina passes from one generation to another in an autosomal dominant pattern, with 50% risk to children. Here, an inherited pathogenic variant in a single gene is the main cause.

16. Family history with autosomal recessive or X-linked inheritance
    Other families show recessive or X-linked patterns. This means both parents may carry silent variants, or the mutation lies on the X chromosome. The pattern explains why some siblings are affected while parents appear normal.

17. Microphthalmia-coloboma spectrum disorders
    Some genetic conditions mainly present with small eyes and colobomas together. These conditions reflect early disruption of optic vesicle growth and fissure closure, so the microphthalmia process itself is a contributing cause of the chorioretinal gap.

18. Vascular or hypoxic insults during eye development
    Experimental work suggests that poor blood flow or hypoxia at key stages can disturb eye morphogenesis and interact with vitamin A signaling. These vascular events may act as environmental hits contributing to uveal coloboma in susceptible embryos.

19. Complex multifactorial interaction (genes plus environment)
    For many individuals, coloboma of the choroid and retina likely results from a combination of genetic susceptibility and environmental exposures. A moderately harmful exposure might only cause coloboma when a child also carries certain risk variants.

20. Truly idiopathic cases with no identified cause
    Even after detailed genetic and environmental evaluation, many cases have no clear cause found. These are called idiopathic colobomas, and they remind clinicians that our current tools do not yet capture all factors in eye development.

Symptoms of coloboma of choroid and retina

Symptoms depend on the size and location of the coloboma, whether one or both eyes are affected, and whether complications like retinal detachment occur.

1. Reduced central visual acuity
   Many people have blurred or reduced sharpness of sight, especially if the macula or area near the centre of the retina is involved. They may struggle to read small print or recognize faces clearly.

2. Patchy or missing areas in the visual field
   The gap in the retina and choroid causes corresponding “blind patches” in the visual field. The person may bump into objects on one side or notice areas where vision suddenly drops out.

3. Light sensitivity (photophobia)
   Some patients feel pain or discomfort in bright light. The abnormal retina and associated eye conditions can make the eye more sensitive, so they may prefer dim environments or sunglasses.

4. Nystagmus (shaking or wobbling eyes)
   When vision is poor from early childhood, the brain struggles to fix the eyes steadily. This can cause rhythmic, uncontrolled eye movements called nystagmus, which can further worsen visual clarity.

5. Strabismus (squint or misaligned eyes)
   Because one eye may see much less than the other, the weaker eye can drift in or out. Parents may notice that the child’s eyes are not pointing in the same direction, especially when tired or focusing on near objects.

6. Poor night vision
   Damage to the retina in the coloboma area, and sometimes broader retinal dysfunction, can reduce the ability to see in low light. The person may have special trouble in dim rooms or at twilight.

7. Distorted vision (metamorphopsia)
   If the coloboma or its edge involves the macula, straight lines may look bent or wavy, and shapes may appear stretched or shrunken. This distortion reflects irregular retinal structure.

8. Glare and poor contrast sensitivity
   Even if they can read an eye chart, many patients describe difficulty in bright sunlight or mist, and trouble distinguishing objects from their background. This relates to abnormal retinal structure and possible secondary changes like cataract.

9. Floaters, flashes, or sudden change in vision
   New floaters (dark spots or cobwebs), flashes of light, or sudden shadows may appear if a retinal tear or detachment develops along the border of the coloboma. These are warning symptoms that need urgent review.

10. Curtain-like shadow over part of the visual field
    A more advanced retinal detachment can cause a “curtain” or “veil” coming over part of the vision from any side. In eyes with chorioretinal coloboma, this is a key sign of serious complication.

11. Headaches and eye strain
    Because the visual system has to work harder to use damaged retinal areas or to rely heavily on one eye, some people develop headaches or eye discomfort, especially after reading or screen use.

12. Difficulty with depth perception and hand-eye coordination
    When one eye is much weaker or when both eyes have large visual field defects, judging distance becomes hard. Children may drop objects, misjudge steps, or struggle with sports that need good 3-D vision.

13. Slow visual development in infancy
    Babies with bilateral coloboma may not fix and follow faces normally or may be slower to respond to visual stimuli. Parents and doctors may notice delayed visual milestones, which prompts an eye check.

14. Amblyopia (lazy eye) in children
    If one eye is much more affected, the brain may “ignore” its input, leading to amblyopia. Without treatment during the critical period, this can cause permanent loss of useful vision from that eye.

15. Emotional and social impact of low vision
    Many patients, especially children and young adults, experience frustration, anxiety, or low confidence due to visual limitations and the need for thick glasses, low-vision aids, or repeated surgeries. Psychosocial support is an important but sometimes overlooked aspect of care.

Diagnostic tests for coloboma of choroid and retina

Diagnosis of coloboma of the choroid and retina uses a mix of eye examination, simple manual tests, laboratory and genetic studies, electrodiagnostic tests, and imaging.

Physical exam–based eye tests

1. External eye inspection and red reflex test
   The doctor first looks at the size and shape of the eyes, eyelids, and pupils, and checks the red reflex with a light. A small globe, abnormal reflex, or white reflex can suggest a posterior defect like chorioretinal coloboma and prompts more detailed fundus examination.

2. Slit-lamp biomicroscopy of the anterior segment
   A slit-lamp is a microscope with a bright beam. It lets the ophthalmologist look at the cornea, lens, and front chamber and also provides a view towards the back of the eye. It helps detect associated problems such as cataract, iris coloboma, or anterior segment dysgenesis that often travel with posterior coloboma.

3. Dilated fundus examination with direct ophthalmoscope
   With eye drops to widen the pupil, the doctor uses a handheld ophthalmoscope to inspect the retina and optic nerve. In choroid and retina coloboma, they see a pale, bowl-shaped area with thin or absent tissue, often in the lower inner retina. This clinical view is central to diagnosis.

4. Dilated fundus examination with indirect ophthalmoscopy
   Indirect ophthalmoscopy uses a head-mounted light and lens to give a wider, stereoscopic view of the retina. It helps map the full size and boundaries of the coloboma and check for retinal breaks or detachments near its edges.

Manual (functional) eye tests

5. Visual acuity testing with eye charts
   The patient reads letters or symbols on standardized charts at distance and near. This test measures how much the chorioretinal coloboma affects central vision and is repeated over time to monitor for change or new complications.

6. Confrontation visual field testing
   In this simple bedside test, the examiner moves fingers in different parts of the patient’s visual field while the patient covers one eye. Missing or reduced responses in certain areas suggest field loss due to the location of the coloboma or from retinal detachment.

7. Color vision testing (e.g., Ishihara plates)
   Colored dot plates are shown, and the patient identifies numbers or patterns. Coloboma that affects the macula or certain retinal pathways can cause color vision problems. Color testing helps document functional impact beyond simple acuity.

8. Amsler grid testing for central distortion
   The Amsler grid is a small square of straight lines. Patients with macular involvement may see wavy, missing, or blurred lines. This simple home or clinic test helps detect distortion or new changes that might signal complications like choroidal neovascularization.

Laboratory and pathological / genetic tests

9. Targeted genetic testing for known coloboma genes (e.g., PAX2, CHD7)
   Blood or saliva samples can be analysed for variants in genes known to cause ocular coloboma and related syndromes. Finding a mutation such as in PAX2 or CHD7 helps confirm a genetic diagnosis, guide systemic screening, and inform family planning.

10. Chromosomal microarray or karyotype analysis
    These tests look for missing or extra chromosome pieces linked to coloboma and other birth defects. In a child with multiple anomalies, chromosomal testing can uncover syndromes like trisomy 13 or structural rearrangements that explain the eye findings.

11. Broader gene panel or exome sequencing
    When targeted tests are negative, a wider panel of eye-development genes or even whole exome sequencing can be used. This approach can identify newer genes controlling optic fissure closure and refine recurrence risk for the family.

12. TORCH and infection screening when syndromic disease is suspected
    Blood tests for infections such as toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) may be requested if there are brain calcifications, hearing loss, or other features pointing to congenital infection that could have contributed to eye malformations.

13. Prenatal genetic testing (CVS or amniocentesis) in future pregnancies
    In families with a known genetic cause for coloboma, sampling placental or fetal cells in a future pregnancy can look for the same mutation or chromosomal change. This does not diagnose the severity of the eye defect but can show whether the fetus carries the known variant.

Electrodiagnostic tests

14. Full-field electroretinogram (ERG)
    ERG measures the electrical response of the whole retina to flashes of light. In eyes with choroid and retina coloboma, the responses may be reduced or abnormal, especially if the defect is large or involves central retina. ERG helps judge how much functioning retina remains.

15. Multifocal ERG
    Multifocal ERG records responses from many small retinal areas separately. It can map localized functional loss over and around the coloboma and is useful when deciding on visual prognosis and rehabilitation plans.

16. Visual evoked potentials (VEP)
    VEP records brain responses to visual stimuli. It is helpful in infants or people who cannot do standard vision tests. In coloboma, VEP can confirm that visual signals still reach the brain and may help distinguish retinal from brain-level causes of poor vision.

Imaging tests

17. Color fundus photography (including wide-field imaging)
    Fundus cameras take detailed photographs of the retina and optic nerve. In chorioretinal coloboma, these photos document the size, shape, and edges of the defect and help track changes such as new tears or neovascularization over time.

18. Optical coherence tomography (OCT)
    OCT uses light waves to create cross-section images of the retina and choroid. In coloboma, OCT shows the depth of the excavation, thinning or absence of retinal layers, and changes at the border where complications such as retinal breaks or choroidal neovascular membranes may form.

19. OCT angiography (OCTA)
    OCTA is a special type of OCT that images blood flow. It can detect abnormal new vessels at the edge of a chorioretinal coloboma, helping doctors diagnose and monitor choroidal neovascularization that might need anti-VEGF injections.

20. B-scan ocular ultrasound and MRI/CT of orbit and brain
    B-scan ultrasound uses sound waves to look through opaque media when the view of the retina is blocked by cataract, corneal opacity, or vitreous hemorrhage. It can show the deep bowl-shaped defect of the coloboma and any retinal detachment. MRI or CT scans of the orbit and brain are sometimes used to assess the size of the globe, optic nerve, and associated brain malformations in syndromic cases.

Non-pharmacological treatments

Important note: These options do not remove the coloboma itself. They aim to protect the eye, improve functional vision, and support quality of life. They must be tailored by an eye-care team, especially for children.

1. Regular specialist eye follow-up
   A retina specialist checks the dilated fundus, monitors the coloboma edges, looks for retinal breaks, and tracks visual changes. Regular visits (often yearly, or more often in childhood) allow early detection of retinal detachment, choroidal neovascularization, cataract, or glaucoma so treatment can start before permanent damage occurs.

2. Early refractive correction (glasses or contact lenses)
   Many patients have high refractive errors or astigmatism. Accurate glasses or contact lenses help focus light on the healthiest part of the retina and can prevent amblyopia (lazy eye) in children. Optometrists and ophthalmologists check refraction regularly, especially during growth, and adjust correction as needed.

3. Low-vision aids
   Magnifiers, telescopic lenses, electronic video magnifiers, large-print reading materials, and screen-magnification software help people with reduced vision use their remaining sight more effectively. Low-vision specialists teach how to position reading material and lighting to improve clarity and reduce eye strain.

4. Vision rehabilitation / visual skills training
   Vision therapists or low-vision rehabilitation teams provide exercises and practical strategies to improve tracking, scanning, and use of the best retinal areas. This training can make reading, mobility, and daily tasks easier and safer, even when acuity is reduced.

5. Amblyopia therapy in children
   If one eye is weaker, patching the stronger eye or using atropine drops in the better eye can force the brain to use the weaker eye during the critical visual development period. This does not repair the coloboma, but it can maximize vision in the affected eye and prevent further functional loss.

6. Strabismus (eye misalignment) management with orthoptic therapy
   Some children with coloboma develop squint. Orthoptic exercises, prisms, or later surgery can improve alignment and binocular function. Early treatment may reduce double vision, improve depth perception, and help appearance and confidence.

7. Protective eyewear
   Strong polycarbonate glasses or sports goggles protect the better eye (and the coloboma eye) from trauma. Because retinal detachment risk is already higher, preventing blunt injury to the eye is very important, especially during sports and rough play.

8. Assistive technology for school and work
   Screen readers, high-contrast themes, zoom functions, and speech-to-text tools help compensate for reduced vision. Schools and workplaces can provide large-print materials, seating near the board, and flexible testing arrangements to support learning and productivity.

9. Optimized lighting and contrast at home
   Bright, even lighting without glare, high-contrast labels, and bold print make navigation and reading safer and easier. Simple changes such as task lamps, contrast tape on steps, and contrasting plates and cups can reduce accidents and improve confidence.

10. Orientation and mobility (O&M) training
    Specialists teach safe walking techniques, use of canes if needed, landmark orientation, and public transport strategies. This is especially helpful when peripheral vision is affected or if the person has had retinal surgery and is afraid of moving around.

11. Educational support and early intervention programs
    Early-intervention teachers, special-education services, and low-vision programs help children with coloboma reach developmental milestones, participate in school, and build independence. Support may include individualized education plans and tailored teaching methods.

12. Psychological counselling and support groups
    Living with a visible eye difference and reduced vision can cause anxiety, low mood, or social worries. Counselling and peer groups help patients and families share experiences, learn coping skills, and reduce isolation.

13. Occupational therapy for daily-living skills
    Occupational therapists teach adapted ways to cook, clean, manage medications, and use devices safely with low vision. They may also advise on workplace changes to support long-term employment and independence.

14. Genetic counselling for families
    Some colobomas are part of genetic syndromes. Genetic counselling explains possible inheritance patterns, recurrence risks in future pregnancies, and options for prenatal testing when appropriate. This helps families make informed decisions and plan ahead.

15. Avoidance of high-risk activities for the eyes
    Contact sports without eye protection, fireworks, and activities with a high risk of head or eye injuries should be limited or adapted. This is because trauma on top of a fragile retina greatly increases the chance of retinal detachment.

16. Prompt treatment of eye infections and inflammation
    Any red, painful eye, sudden blur, or discharge should be seen quickly. Early treatment of conjunctivitis, keratitis, or uveitis reduces the risk of scarring, glaucoma, or further retinal damage in eyes already at risk.

17. Monitoring and early management of cataract
    Cataract is common in eyes with chorioretinal coloboma. Regular lens checks and timely cataract surgery planning can restore significant vision, especially when the macula is relatively healthy.

18. Monitoring and management of glaucoma risk
    Abnormal drainage structures or associated anomalies can increase intraocular pressure. Regular pressure checks and optic nerve assessment allow early medical or surgical treatment, protecting remaining vision.

19. Lifestyle measures for general eye health
    Not smoking, managing blood pressure and diabetes, exercising regularly, and protecting eyes from UV light all help the overall health of the retina and optic nerve, which is especially important in an already compromised eye.

20. Family training on warning symptoms
    Families learn to recognize sudden floaters, flashes, loss of side vision, or a dark curtain over vision and understand that these are emergencies. Quick response can make the difference between saving and losing vision when retinal detachment or bleeding occurs.

---

Drug treatments for complications

Safety note: There is no drug that “cures” coloboma itself. Medicines treat complications such as choroidal neovascularization (CNV), glaucoma, inflammation, or infection. Doses below are typical adult label information and must not be used for self-treatment, especially in children. Only an eye specialist should decide which drug, dose, and schedule are right for a specific patient.

1. Ranibizumab intravitreal injection (Lucentis and biosimilars)
   Ranibizumab is an anti-VEGF biologic injected into the vitreous cavity, usually 0.5 mg (0.05 mL) once a month at the start, then at intervals decided by the retina specialist. It binds VEGF-A and reduces leakage and growth of abnormal blood vessels in CNV, including CNV reported in coloboma. Side effects include eye pain, raised intraocular pressure, intraocular inflammation, and rare infection or retinal detachment.

2. Ranibizumab port-delivery system (Susvimo)
   Susvimo is a small implant placed surgically and refilled periodically with ranibizumab, aiming to provide sustained anti-VEGF levels. It is approved for neovascular AMD and being explored in other VEGF-driven conditions. Typical refill intervals are every several months, but the schedule is individualized. Risks include conjunctival erosion, endophthalmitis, and implant dislocation, so it is reserved for carefully selected cases.

3. Aflibercept intravitreal injection (Eylea and related products)
   Aflibercept is a fusion protein that traps VEGF-A, VEGF-B, and placental growth factor. It is labeled for neovascular AMD, diabetic macular edema, and other retinal vascular diseases, using 2 mg intravitreal injections at intervals starting monthly, then every 8–12 weeks. In CNV related to coloboma, it may be used off-label in a similar way. Common risks include transient pressure rise and rare but serious endophthalmitis or retinal detachment.

4. Biosimilar ranibizumab products (e.g., Byooviz)
   Ranibizumab biosimilars provide similar anti-VEGF action and labeled dosing to the reference ranibizumab product, such as 0.5 mg intravitreal injection monthly at first. They may reduce cost barriers in long-term CNV treatment. Side-effect profiles are similar, including intraocular inflammation, bleeding, and infection risk, so injections must be done with strict sterile technique.

5. Timolol maleate ophthalmic solution (Timoptic and generics)
   Timolol is a non-selective beta-blocker eye drop used to lower intraocular pressure in glaucoma and ocular hypertension. Typical adult dosing is one drop of 0.25–0.5% solution in the affected eye(s) twice daily, adjusted by the doctor. It works by reducing aqueous humor production. Side effects include burning, dry eye, slow heart rate, low blood pressure, and bronchospasm, so it is avoided in asthma or severe COPD.

6. Timolol gel-forming solution (Timolol GFS, Istalol)
   Gel-forming timolol allows once-daily dosing (for example, 0.5% once in the morning) while maintaining pressure control, which may improve adherence. It shares the same mechanism and systemic cautions as standard timolol drops. Patients should avoid touching the bottle tip to the eye and must press on the inner corner of the eye to reduce systemic absorption if advised.

7. Dorzolamide–timolol fixed-combination drops
   This combination adds a topical carbonic anhydrase inhibitor to timolol, further lowering intraocular pressure by both reducing fluid production and improving outflow. The usual adult dose is one drop twice daily, but the schedule is set by the doctor. Local side effects include burning, bitter taste, and rarely corneal changes; systemic effects are similar to timolol alone.

8. Latanoprost ophthalmic solution
   Latanoprost is a prostaglandin analog given once nightly (one drop in the affected eye) to increase uveoscleral outflow and reduce intraocular pressure. It is widely used in glaucoma and is helpful when coloboma eyes also develop high pressure. Common side effects are eye redness, eyelash growth, iris darkening, and mild irritation.

9. Travoprost or bimatoprost prostaglandin analogs
   These drops are used similarly to latanoprost (one drop at night) and lower intraocular pressure mainly by increasing outflow. They are useful alternatives if latanoprost is not tolerated or insufficient. Side effects include red eyes, eyelash changes, periocular skin darkening, and rarely macular edema in high-risk patients.

10. Topical carbonic anhydrase inhibitors (dorzolamide or brinzolamide)
    These drops reduce aqueous humor production by blocking carbonic anhydrase in the ciliary body. They may be given two or three times daily as adjuncts to prostaglandins or beta-blockers. Side effects include burning, blurred vision, and rarely corneal edema; systemic acidosis is much less common than with oral forms.

11. Topical alpha-agonist (brimonidine)
    Brimonidine both decreases aqueous production and increases uveoscleral outflow. It is often added as a second or third glaucoma drug and is usually dosed three times daily. Side effects include allergy (red, itchy eyes), dry mouth, fatigue, and in small children there is a risk of CNS depression, so pediatric use is very cautious.

12. Topical corticosteroid drops (e.g., prednisolone acetate 1%)
    Steroid drops reduce intraocular inflammation that may occur after surgery or with associated uveitis. Typical short-term dosing might be one drop four times daily, then taper, under close medical supervision. Benefits are reduced pain, redness, and tissue damage, but risks include steroid-induced glaucoma, cataract, and delayed wound healing.

13. Topical cycloplegic drops (e.g., atropine or cyclopentolate)
    Cycloplegics temporarily paralyze accommodation and dilate the pupil, helping relieve pain from ciliary spasm and preventing posterior synechiae during inflammation. Dosing and duration depend on the drug and indication. Side effects include light sensitivity, blurred near vision, and, systemically, flushing or dry mouth if too much is absorbed.

14. Topical non-steroidal anti-inflammatory drops (e.g., ketorolac)
    NSAID eye drops are often used around cataract surgery to reduce inflammation and macular edema risk. They inhibit cyclo-oxygenase enzymes involved in prostaglandin production. Common side effects are burning and stinging; long-term use may very rarely cause corneal problems.

15. Topical antibiotic drops (e.g., moxifloxacin)
    Broad-spectrum antibiotics are used short-term after intravitreal injections or surgery if infection risk is high, or to treat bacterial conjunctivitis. Typical dosing is frequent in the first days (for example, four times daily), then taper. Overuse can promote resistance and may cause local irritation or allergy.

16. Artificial tears and lubricating gels
    Preservative-free artificial tears and night gels improve comfort and surface health, especially when patients use multiple pressure-lowering drops or have exposure from abnormal lids. Regular lubrication supports the cornea, reduces foreign-body sensation, and may improve visual clarity. Side effects are usually mild and limited to temporary blur or irritation.

17. Oral acetazolamide
    In acute or difficult cases, acetazolamide tablets can quickly reduce intraocular pressure by decreasing aqueous production. Dosing is strictly individualized and monitored by the doctor because systemic effects include tingling fingers, fatigue, kidney stone risk, and metabolic acidosis. It is used short-term or as a bridge to surgery.

18. Systemic corticosteroids
    When there is severe associated inflammation or optic nerve swelling, short courses of oral or intravenous steroids may be used. They powerfully reduce immune activity and swelling but carry important risks: weight gain, mood changes, raised blood sugar and blood pressure, infection risk, and bone loss. Duration is kept as short as clinically possible.

19. Systemic immunosuppressants (in special syndromic cases)
    Rarely, coloboma occurs with systemic autoimmune disease needing medicines like methotrexate, azathioprine, or biologics. These suppress overactive immunity and protect tissues, but they require close monitoring for liver, bone-marrow, and infection side effects. They are prescribed only by specialists.

20. Pain-control medicines (paracetamol, etc.)
    When eye pain occurs after surgery or during acute complications, simple analgesics may be used as part of a complete treatment plan. They do not treat the coloboma or retinal disease directly, but they improve comfort and help patients tolerate other necessary procedures and drops.

---

Dietary molecular supplements

Diet and supplements cannot repair a structural coloboma, but they may support overall retinal and nerve health. Evidence is strongest for age-related macular degeneration, not specifically for coloboma, so any supplement plan should be discussed with a doctor to avoid overdose or drug interactions.

1. Omega-3 fatty acids (EPA/DHA)
   Omega-3s from fish oil or algae help maintain cell membranes in the retina and may reduce inflammation. Typical supplemental doses in adults are around 500–1000 mg combined EPA/DHA daily, but exact dosing should be individualized. People on blood thinners or with bleeding disorders must be cautious because higher doses can increase bleeding risk.

2. Lutein
   Lutein is a carotenoid concentrated in the macula that helps filter blue light and may reduce oxidative damage. Supplements often provide 10 mg per day, sometimes combined with zeaxanthin. It is generally well tolerated, but very high intakes from pills are unnecessary if diet is rich in leafy greens and colored vegetables.

3. Zeaxanthin
   Often paired with lutein at 2 mg per day in eye-health formulas, zeaxanthin works as an antioxidant and light filter in the central retina. It may support macular function and contrast sensitivity, which is useful when healthy retina must compensate for colobomatous areas.

4. Vitamin A (retinol or beta-carotene)
   Vitamin A is essential for photoreceptor function and the visual cycle. Mild deficiency can cause night blindness and dry eye. Supplement doses must be carefully controlled, because excess vitamin A can damage the liver and is dangerous in pregnancy. Many people do best getting vitamin A from food rather than high-dose pills.

5. Vitamin C
   Vitamin C is a water-soluble antioxidant that supports collagen in the sclera and blood vessel walls. Many eye-health formulations include 500 mg per day. It is usually safe, but very high doses can cause stomach upset or kidney stone risk in susceptible people.

6. Vitamin E
   Vitamin E protects cell membranes from oxidative damage. Doses around 200–400 IU per day are often used in eye supplements, but very high doses may increase bleeding risk, especially with anticoagulant drugs. People with clotting disorders should only use it under medical advice.

7. Zinc
   Zinc is important for many enzymes in the retina and for immune function. The AREDS formulations used 25–80 mg per day, but long-term high doses can cause copper deficiency and stomach upset. Many modern formulas use lower zinc doses, and any supplement should consider diet and other medications.

8. Copper
   Copper is added to high-dose zinc supplements to prevent zinc-induced copper deficiency. Typical doses are 1–2 mg per day. Copper should rarely be taken alone at high doses; it is usually part of a balanced eye-health formula, especially when zinc is included.

9. B-complex vitamins (B6, B12, folate)
   B vitamins support nerve function and homocysteine metabolism. They may help general vascular health, which indirectly supports the retina and optic nerve. Doses vary widely in supplements; very high B6 doses over long periods may cause nerve problems, so balanced formulations are preferred.

10. Vitamin D
    Vitamin D modulates immunity and bone health and may influence overall neuro-ocular health. Many people are deficient. Typical maintenance doses are in the range of 600–2000 IU per day, but testing and medical guidance are important, because excessive vitamin D can cause high calcium and kidney damage.

---

Immunity-booster, regenerative and stem-cell–related approaches

Right now, there are no approved stem-cell or regenerative drugs that specifically treat coloboma of the choroid and retina. However, research in retinal gene therapy and cell therapy is growing. It is very important not to seek unregulated “stem-cell injections” because they have caused serious harm, including blindness, in other eye conditions.

1. Gene therapy for inherited retinal diseases (concept)
   Treatments like voretigene neparvovec for RPE65-related disease show that replacing faulty genes can restore some retinal function in other conditions. Similar strategies might one day target pathways related to coloboma, but at present no gene therapy is approved for coloboma itself.

2. Retinal pigment epithelium (RPE) cell transplantation
   Clinical trials are exploring transplanting lab-grown RPE cells onto damaged retina in selected diseases. For coloboma, the main challenge is the structural absence of tissue, so this approach is still experimental and not standard care. Participation should only occur in regulated clinical trials.

3. Retinal progenitor or photoreceptor cell therapy
   Researchers are studying injections or sheets of retinal progenitor cells to replace lost photoreceptors. In coloboma, however, supporting layers like choroid and RPE may also be missing, so the environment may not support new cells. This makes the science complex and long term.

4. Systemic immune support through vaccines and general health
   While not “regenerative”, staying up to date with routine vaccines and managing chronic diseases reduces the chance of severe infections or hospitalizations that could interrupt eye care. A strong general health base supports better surgical recovery and long-term ocular outcomes.

5. Avoidance of unproven “immune-boosting” products
   Many herbal mixtures and alleged immune boosters have no high-quality evidence for eye benefit and can interact with prescription drugs. Patients with coloboma should discuss any supplement with their doctor instead of relying on marketing claims.

6. Clinical trial participation where appropriate
   Carefully designed clinical trials are the only safe route to access experimental regenerative therapies. Trial teams closely monitor safety, collect data, and protect participants with ethical oversight. Patients and families can ask their specialists if any reputable trials are available for their situation.

---

Surgical and procedural treatments

1. Pars plana vitrectomy with retinal detachment repair
   Retinal detachment is a major risk in chorioretinal coloboma and is technically challenging because the retina over the coloboma is thin and lacks normal support. Surgeons may combine vitrectomy, internal drainage of fluid, endolaser around breaks and the coloboma edge, and gas or silicone-oil tamponade. The aim is to reattach the retina and prevent redetachment, though multiple surgeries may be needed.

2. Prophylactic laser photocoagulation around coloboma margins
   Some specialists apply laser burns along the border of the coloboma to “weld” the retina and reduce the risk of retinal detachment from breaks near the edge. This is not suitable for every eye, but in selected cases it may lower future detachment risk. The decision depends on age, visual status, and detailed retinal findings.

3. Intravitreal anti-VEGF injection procedures for CNV
   When CNV develops at or near the coloboma, intravitreal injection of anti-VEGF agents such as ranibizumab or aflibercept can reduce leakage and improve or stabilize vision. The procedure is usually done in a clean clinic setting with local anesthetic. Monitoring continues over months to years, and repeated injections are often required.

4. Cataract surgery
   Cataract is common in eyes with coloboma and can significantly reduce vision. Phacoemulsification with intraocular lens implantation is planned carefully, considering retinal status and any associated anomalies. Surgery can greatly improve clarity if the central retina is functional, but the prognosis is limited when the macula or optic nerve are heavily involved by coloboma.

5. Glaucoma surgery
   If glaucoma in a coloboma eye is not controlled by drops, procedures such as trabeculectomy, drainage devices, or minimally invasive glaucoma surgery may be considered. These aim to create new outflow pathways for aqueous humor and protect the optic nerve. Surgical planning is complex when anatomy is abnormal, so it is done by experienced glaucoma surgeons.

---

Prevention of complications

1. Attend all scheduled eye appointments, even if vision feels stable.

2. Learn and act quickly on warning signs like flashes, floaters, or a dark curtain over vision.

3. Use protective eyewear during sports, DIY work, and other risky activities.

4. Control general health problems such as diabetes, blood-pressure, and cholesterol.

5. Avoid smoking and exposure to second-hand smoke.

6. Maintain a healthy weight and exercise regularly for vascular health.

7. Use good lighting and high-contrast environments to reduce falls and eye strain.

8. Follow postoperative instructions exactly after any eye surgery or injection.

9. Discuss any new medicines or supplements with the eye doctor to avoid harmful interactions.

10. Encourage family screening and genetic counselling if there is more than one affected relative.

---

When to see doctors

People with choroid and retina coloboma should see an ophthalmologist or retina specialist regularly, often at least once a year, and more often in childhood or when complications are active. An urgent visit is needed for sudden new floaters, flashes of light, a gray or black curtain in part of the visual field, sudden blurred or distorted central vision, severe eye pain, redness with vision loss, or after any eye injury. These symptoms may signal retinal detachment, CNV bleeding, infection, or acute glaucoma and require immediate treatment to protect vision.

---

Diet – what to eat and what to avoid

1. Eat plenty of leafy green vegetables (spinach, kale), colorful fruits, and vegetables for natural lutein, zeaxanthin, and vitamins.

2. Include fatty fish (salmon, sardines, mackerel) two or more times a week for omega-3 fatty acids, unless medically contraindicated.

3. Use nuts and seeds (walnuts, almonds, sunflower seeds) in moderate amounts for healthy fats and vitamin E.

4. Choose whole grains and high-fiber foods to support overall cardiovascular health.

5. Drink enough water to stay well hydrated, unless fluid intake is restricted for another medical condition.

6. Limit highly processed foods, trans-fats, and sugary drinks that contribute to vascular disease.

7. Reduce very salty foods if you have high blood pressure or heart disease.

8. Avoid smoking and vaping; tobacco harms blood vessels and the retina.

9. Do not take high-dose vitamin A or other fat-soluble vitamins without medical advice, because overdose can be dangerous.

10. Discuss any strong herbal or “eye-health” supplements with your doctor, especially if you already take prescription medicines.

---

Frequently asked questions (FAQs)

1. Can coloboma of the choroid and retina be cured?
   No. The missing tissues did not form before birth and cannot be replaced with current routine treatments. However, many complications, such as retinal detachment, CNV, cataract, or glaucoma, can be managed, and low-vision care can significantly improve daily functioning.

2. Will my vision always get worse?
   Not always. Some people have stable vision for life, especially if the macula and optic nerve are spared and complications are prevented or treated quickly. Others may lose vision due to detachment or CNV. Regular monitoring and rapid treatment of problems give the best chance of preserving sight.

3. Is coloboma inherited?
   Coloboma can be isolated or part of genetic syndromes. Sometimes it follows patterns such as autosomal dominant or recessive inheritance; sometimes it is sporadic. Genetic counselling can help clarify risks for future children and options for testing.

4. Can my child with coloboma live a normal life?
   Many children with coloboma attend normal school, play sports with eye protection, and build independent adult lives, especially with early low-vision support and educational accommodations. The level of visual limitation depends on how much of the retina and optic nerve is involved.

5. Are screens and phones harmful to eyes with coloboma?
   Screen use does not worsen the coloboma itself, but long sessions can cause eye strain and dry eye. Using the right font size, good lighting, regular breaks, and lubricating drops when needed can make digital work safer and more comfortable.

6. Can I drive if I have coloboma?
   Driving depends on meeting legal visual-acuity and visual-field standards in your country. Some people with unilateral coloboma and good vision in the other eye can drive; others with more severe involvement cannot. Your eye doctor and licensing authority will advise based on testing.

7. Will my child need special schooling?
   Not necessarily. Many children do well in mainstream schools with simple accommodations like front-row seating, large-print materials, and extra time for reading. Some children with severe vision loss benefit from schools with specialist low-vision resources. Early assessment helps tailor support.

8. Does pregnancy affect coloboma or its complications?
   Pregnancy changes blood volume and hormones, which can influence some eye diseases, though specific data for coloboma are limited. Women with significant retinal disease or glaucoma should have pre-pregnancy counselling and closer follow-up during pregnancy.

9. Can contact sports cause problems?
   Yes, because any strong blow to the head or eye increases retinal detachment risk in a structurally weak retina. If you play sports like football, basketball, or martial arts, strict use of protective eyewear and sometimes avoiding high-impact activities are recommended.

10. Should brothers and sisters of an affected child have eye exams?
    Yes. A full eye exam can detect milder or asymptomatic colobomas, refractive errors, or other eye problems early, so that treatment can start if needed.

11. Is laser treatment always needed around the coloboma?
    No. Prophylactic laser is considered on a case-by-case basis. In some eyes it may help reduce detachment risk; in others the risks may outweigh the benefits. The retina specialist decides based on age, visual status, and the exact anatomy of the coloboma.

12. How often do I need anti-VEGF injections if CNV develops?
    Injection schedules are individualized. Many patients start with monthly injections, then continue monthly or at gradually extended intervals depending on optical coherence tomography (OCT) and vision results. Some need long-term treatment for many years to keep CNV inactive.

13. Can I stop glaucoma drops once my pressure is controlled?
    Usually not without your doctor’s guidance. Glaucoma is a chronic disease, and stopping drops can allow pressure to rise silently and damage the optic nerve. Any changes in therapy must be supervised by an ophthalmologist, especially in an eye already vulnerable from coloboma.

14. Do supplements replace medical or surgical treatment?
    No. Supplements can only support general eye health. They do not replace injections, surgery, or glaucoma medicines when these are needed. Using supplements should be an add-on, not an alternative, to scientifically proven treatments.

15. Which doctor should manage coloboma of choroid and retina?
    Ideally, care is shared between a general ophthalmologist and a retina specialist, and sometimes a glaucoma specialist and low-vision team. This multidisciplinary approach provides full coverage: monitoring structure, controlling pressure, managing complications, and supporting daily-living skills.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 09, 2025.